Overview

A Double-Blind, Randomized Control Trial Comparing Botulinum Toxin Type A (Botox) and Placebo in the Treatment of Idiopathic Clubfoot

Status:
Completed
Trial end date:
2015-09-30
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to continue the work from the previous review study and determine the effectiveness of Botox in treating patients with idiopathic clubfoot by comparing outcomes of subjects treated with manipulation and casting plus Botox (treatment group) to those treated with manipulation and casting plus placebo (control group). The null hypothesis is that manipulation and casting plus Botox is not an effective treatment for idiopathic clubfoot. The alternate hypothesis is that manipulation and casting plus Botox is an effective treatment for idiopathic clubfoot.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of British Columbia
Treatments:
abobotulinumtoxinA
Botulinum Toxins
Botulinum Toxins, Type A
incobotulinumtoxinA
onabotulinumtoxinA
Criteria
Inclusion Criteria:

1. children presenting with idiopathic clubfoot at BC Children's Hospital and Hospital
for Sick Children

2. children ranging in age from 1 day to 2 months old

3. children who have reached hindfoot stall

4. children with complete pre-study data *From protocol, hindfoot stall is defined:
"following initial manipulation and casting of clubfoot, when the forefoot can be
abducted beyond 60 degrees but hindfoot equinus persists, requiring need for further
intervention to correct the clubfoot deformity"

Exclusion Criteria: